Needham Downgrades Centessa Pharmaceuticals to Hold

Benzinga Newsdesk www.benzinga.com Negative 92.6%

Neg 92.6% Neu 0% Pos 0%

Needham analyst Ami Fadia downgrades Centessa Pharmaceuticals (NASDAQ:CNTA) from Buy to Hold.

Comments

No comments yet. Be the first!